Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Non-alcoholic Steatohepatitis Clinical Trials

9 recruiting trials for Non-alcoholic Steatohepatitis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
9
Total Trials
9
Recruiting Now
0
Phase 3 Trials
8
Sponsors

Recruiting Trials

RECRUITINGNCT06676813

Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.

The aims of this study are as follows: To compare the role of alternate-day fasting over standard medical management alone to reverse NASH.

Sponsor: Institute of Liver and Biliary Sciences, IndiaEnrolling: 721 location
RECRUITINGNCT04365855

The Olmsted NAFLD Epidemiology Study (TONES)

Researchers are assessing the prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in the population and assembling a well-characterized...

Sponsor: Mayo ClinicEnrolling: 8001 location
RECRUITINGPhase 1NCT05945537

A Study of INI-822 in Healthy Volunteers and Participants with Non-alcoholic Steatohepatitis (NASH) or Presumed NASH

This Phase 1 trial will explore the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single and multiple ascending doses of INI-822 in healthy volunteers...

Sponsor: Inipharm Australia Pty LtdEnrolling: 1047 locations
RECRUITINGNCT06138821

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally. While weight loss through lifestyle modification is the...

Sponsor: Pichamol Jirapinyo, MD, MPHEnrolling: 1322 locations
RECRUITINGNCT04190849

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)

The EU-PNAFLD (The European Paediatric NALFD Registry) will be a network composed of European centres involved in the care of children with NAFLD, and will include Hepatologists,...

Sponsor: Cambridge University Hospitals NHS Foundation TrustEnrolling: 20003 locations
RECRUITINGPhase 2NCT05480696

Soluble Fibre Supplementation in NAFLD

The FIND study will look at the effect of a nutritional mixed fibre supplement, oligofructose and inulin (OF+INU), on children with non-alcoholic fatty liver disease. In this...

Sponsor: McMaster UniversityEnrolling: 601 location
RECRUITINGNCT04666402

Integrated Diagnostics for Early Diagnosis of Liver Disease

This is an observational study that will explore the hypothesis that by combining data from patients with liver disease with novel blood biomarkers, single nucleotide polymorphism...

Sponsor: Manchester University NHS Foundation TrustEnrolling: 12001 location
RECRUITINGNCT05623150

CHronic Hepatopathies Associated with ALcohol Consumption and MetAbolic Syndrome

The aim is to determine the metabolic factors, host immune factors, and medical imaging data associated with the development of HepatoCellular Carcinoma (HCC) in patients with...

Sponsor: Institut National de la Santé Et de la Recherche Médicale, FranceEnrolling: 7101 location
RECRUITINGNCT04690972

"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and...

Development of preclinical translational models for chronic liver tumors and diseases study, such as spheroids cultured in autologous medium and murine xenograft models to test...

Sponsor: Institut National de la Santé Et de la Recherche Médicale, FranceEnrolling: 8001 location